For research use only. Not for therapeutic Use.
Levosimendan is a calcium sensitizer that can cause increased cardiac contractility by binding troponin C, promotes vasodilation by activating ATP-sensitive potassium channels on vascular smooth muscle cells, and performs a cardioprotective function by prompting the opening of mitochondrial potassium channels in cardiomyocytes. It also has been reported to inhibit phosphodiesterases 3 and 4 in left ventricular cardiac tissue.
Catalog Number | A000693 |
CAS Number | 141505-33-1 |
Synonyms | 141505-33-1; Simdax; (R)-Simendan; Levosimendan [INN]; Levosimendanum |
Molecular Formula | C14H12N6O |
Purity | ≥95% |
Target | Metabolic Enzyme/Protease |
Storage | -20°C |
IUPAC Name | 2-[[4-[(4R)-4-methyl-6-oxo-4,5-dihydro-1H-pyridazin-3-yl]phenyl]hydrazinylidene]propanedinitrile |
InChI | 1S/C14H12N6O/c1-9-6-13(21)19-20-14(9)10-2-4-11(5-3-10)17-18-12(7-15)8-16/h2-5,9,17H,6H2,1H3,(H,19,21)/t9-/m1/s1 |
InChIKey | WHXMKTBCFHIYNQ-SECBINFHSA-N |
SMILES | CC1CC(=O)NN=C1C2=CC=C(C=C2)NN=C(C#N)C#N |